Updated May 19, 2026: The BALANCE Model Part D pilot was canceled April 21, 2026 — the Medicare GLP-1 Bridge is now the ONLY federal Medicare obesity pathway through December 31, 2027. Four drugs covered at a $50/month flat copay: Foundayo, Wegovy injection, Wegovy oral tablet, a…
Updated May 2026: FDA proposed on April 30 to permanently remove semaglutide, tirzepatide, and liraglutide from the 503B Bulks List — effect…
IvyRx offers compounded semaglutide from $175/month and tirzepatide from $275/month with a rare flat-rate model — your price never increases…
Updated May 18, 2026 with Week 5 IQVIA data: 10,248 weekly Rx (+40% week-over-week re-acceleration). Oral Wegovy produces 16.6% body weight …
Verified May 8, 2026: On April 30, FDA proposed permanently removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bul…
Verified May 2026: Tirzepatide starts at 2.5 mg once weekly (non-therapeutic starter dose), escalates by 2.5 mg every 4 weeks to a maximum o…
Updated May 2026: 5 next-gen obesity drugs in Phase 3. Retatrutide (Lilly) 28.7% weight loss. CagriSema (Novo): REDEFINE-1 22.7% (obesity), …
Updated April 29, 2026: Foundayo (orforglipron) is the first non-peptide GLP-1 pill for weight loss, FDA-approved April 1, 2026. Produces 12…
Verified April 2026: Zepbound and Mounjaro are the exact same drug (tirzepatide) at the same doses. Mounjaro was FDA-approved May 2022 for T…
Verified April 2026: Zepbound (tirzepatide) side effects from the SURMOUNT clinical trials — nausea affects 24-29% of patients (vs 8% placeb…
How much do GLP-1 medications cost in 2026? Wegovy, Zepbound, Ozempic, Mounjaro & Foundayo range from $25–$1,350/month. With insurance + sav…
HHS Secretary Robert F. Kennedy Jr. is considering a regulatory framework for Medicare and Medicaid GLP-1 coverage, but only for patients wh…
Medicare will begin covering GLP-1 weight loss medications at $50/month starting July 2026. Here's who qualifies, how it works, and what com…
FDA-approved GLP-1 receptor agonists for weight loss — 2026 guide. Eligibility: BMI 30+ (or 27+ with comorbidity). Semaglutide produces 14.9…
Verified April 2026: Brand-name Wegovy is $349/mo via NovoCare, Zepbound starts at $299/mo via LillyDirect. Compounded semaglutide is banned…
Verified April 2026: GLP-1 patients lose 2-5 pounds in their first month. Appetite suppression starts week 1-2. Nausea peaks at week 4 dose …
Verified April 2026: Retatrutide (Eli Lilly, LY-3437943) achieved 28.7% body weight loss in Phase 3 TRIUMPH trials — nearly double semagluti…
Verified April 2026: Zepbound (tirzepatide) produces 20.9% body weight loss vs Wegovy's (semaglutide) 14.9% per the SURMOUNT-1 and STEP-1 tr…
Verified April 2026: Medicare Part D begins covering Wegovy and Zepbound for weight loss July 1, 2026 via the Medicare GLP-1 Bridge program.…
Verified April 2026: Ozempic and Wegovy are both semaglutide from Novo Nordisk. Ozempic ($1,028/mo list) is approved for type 2 diabetes at …
Verified April 2026: Oral Wegovy (25mg daily pill) produces 16.6% weight loss per the OASIS trial vs 14.9% for injectable Wegovy (2.4mg week…
Verified April 2026: Tirzepatide produces 20.2% weight loss vs semaglutide's 13.7% in the head-to-head SURMOUNT-5 trial (NEJM). Tirzepatide …
Verified April 2026: The 7 worst foods on Ozempic, Wegovy, Zepbound — fried food, sugary drinks, red meat portions, raw cruciferous veg, car…
Verified April 2026: 44% of Wegovy patients report nausea, 30% diarrhea, 24% vomiting in STEP-1 trial. Only 7% discontinued for side effects…
Verified April 2026: Tirzepatide costs $149/mo via Enhance MD (compounded), $299/mo via LillyDirect (brand Zepbound 2.5mg vial), $449/mo for…
Verified April 2026: Tirzepatide compounding enforcement began March 2025 after FDA removed it from the shortage list. Narrow medical-necess…
Verified April 2026: Zepbound savings card cuts copay to $25/fill ($1,300 max annual savings) with commercial insurance. Mounjaro savings ca…
Verified April 11, 2026: Foundayo (orforglipron) shipped to LillyDirect patients starting April 6. First-week fill rate hit 94% within 48 ho…
Verified April 11, 2026: The FDA issued 14 new warning letters to GLP-1 compounders between March 12 and April 8, 2026 — the largest enforce…
Verified April 11, 2026: 81 days until the Medicare GLP-1 Bridge launches July 1, 2026. Complete prep checklist: Part D enrollment verificat…
Clinical trials show 15–17% body weight loss with semaglutide over 68 weeks. Here's what to expect month by month, backed by data from the S…
GLP-1 patches sold online don't contain semaglutide or tirzepatide — they're herbal supplements. Here's what the science says and what actua…
Two of the biggest telehealth platforms now offer branded Wegovy and GLP-1 programs. We compare Ro and Hims on pricing, medications, insuran…
The FDA just approved Eli Lilly's Foundayo (orforglipron) — the only GLP-1 weight loss pill with no food, water, or timing restrictions. Her…
Four programs our readers click through most.
Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.